Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1007/s00595-016-1385-6
Published Online: 2016-08-22
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nitta, Hidetoshi
Nakagawa, Shigeki
Kaida, Takayoshi
Arima, Kota
Higashi, Takaaki
Taki, Katsunobu
Okabe, Hirohisa
Hayashi, Hiromitsu
Hashimoto, Daisuke
Chikamoto, Akira
Ishiko, Takatoshi
Beppu, Toru
Baba, Hideo
License valid from 2016-08-22